In one of the articles on this site it says:
“According to the American Urological Association, people with low-risk NMIBC should not receive BCG. Gemcitabine may be given as a single intravesical treatment within 24 hours after surgery if you have low-risk NMIBC. For intermediate-risk, you may benefit from BCG or chemotherapy.3,7”
How would anyone know if the disease was low/intermediate/high risk within 24 hours after TURBT?
Tissue samples likely aren’t even at pathology lab that soon.